-
Additional file 3: of Post-marketing withdrawal of anti-obesity medicinal pro...
Profiles of 23 centrally acting anti-obesity medicinal products withdrawn over the last 50Â years because of adverse drug reactions. (PDF 246 kb) -
dedup_wf_001--a89be06451b6e2c0fbef46fc794df8c4
Additional file 3: Table S2. Characteristic of severe and non-severe complications of Plasmodium knowlesi. -
Additional file 2 of Risk factors for the critical illness in SARS-CoV-2 infe...
Additional file 2: Supplementary Table S2. Performance of different models for predicting critical illness in SARS-CoV-2 infection. -
dedup_wf_001--1d0ce5e2ca085582ff8bb30ed24e7af6
Table S1. Description of data: Studies reporting non-pharmacological treatment efficacy in patients with mild COPD. (PDF 17 kb) -
dedup_wf_001--91bb84f1d83c85f227b87849540771af
Additional file 4: Table S3. Characteristic of severe Plasmodium knowlesi and P. falciparum. -
Additional file 1: of Genetic characterization and molecular survey of Babesi...
a. Alignment of partial nucleotide sequences of rap-1a gene from different Chinese isolates. FJ2: B. bovis rap-1a isolate Fujian 2; GS: B. bovis rap-1a isolate Guansu; FJ1: B.... -
Additional file 1 of Prevalence and associated risk factors for Hepatitis B a...
Additional file 1: A questionnaire used for collect data on socio-demographic, risk factors, knowledge, attitude, and practice of refugees towards HBV and HCV infections. -
Additional file 1: of Chikungunya virus infection in Indonesia: a systematic ...
Individual characteristics and risk bias assessment of included studies in the systematic review (PDF 532 kb) -
Additional file 2: of Epidemiology and burden of influenza in healthy childre...
Table S1. Medication use associated with confirmed influenza episodes by region (PDF 8 kb) -
Additional file 1: of Clinical and virological factors associated with gastro...
Gastrointestinal symptomsâ proportion by respiratory pathogens infection found in previous studies. (PDF 210Â kb) -
Additional file 2: of Available, Bed-sided, Comprehensive (ABC) score to a di...
Comparison of the two patient cohorts. (PDF 149Â kb) -
Additional file 1 of Hemophagocytic lymphohistiocytosis in critically ill pat...
Additional file 1: Supplemental Table S1. HLH-2004 criteria and HScore (7, 9). AST, aspartate aminotransferase; hb, hemoglobin; mM, mmoles/liter; plt, platelets; U,... -
Additional file 1: of Patientsâ ability to read and understand dosing instruc...
Patientsâ data collection sheet (English) in hospital and community pharmacy settings. (PDF 844 kb) -
of Low levels of viral suppression among refugees and host nationals accessin...
of Low levels of viral suppression among refugees and host nationals accessing antiretroviral therapy in a Kenyan refugee camp -
Additional file 3: of Post-marketing withdrawal of 462 medicinal products bec...
Table S1. List of medicinal products withdrawn because of adverse drug reactions. (PDF 2375 kb) -
Additional file 1: of Estimating severity of influenza epidemics from severe ...
Raw weekly numbers of admissions, APACHE IV score and mortality in adult ICUs (2007â 2016). Footnote: gray shading: influenza epidemic weeks as derived from ILI sentinel... -
Additional file 7: of Quantitative benefit-risk assessment of methylprednisol...
Process for selecting published studies used to estimate effectiveness and risk of non-serious adverse effects. (PDF 97Â kb) -
dedup_wf_001--6151b8e737921fa3ed8385da23cd0252
Screening outcomes. Full analysis of screening outcomes. (PDF 88 kb) -
Additional file 1 of The role of antifungals in the management of patients wi...
Additional file 1: Table S1. Fungal nomenclature for common allergenic fungi. -
dedup_wf_001--236c6e844b4bfc76bcad7d714cbcbb7f
This questionnaire was designed to collect direct costs of treating a patient. (PDF 566Â kb)
